Evidence map›Paper›PMID 39958937›Full record

ArticleFrontiers in cellular and infection microbiology2025

A novel strategy for eradication of staphylococcal biofilms using blood clots.

Kayla E Grooters, Sheridan L Hayes, David M Richter, Jennifer C Ku, Robert Sawyer, Yong Li

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Biofilm Production, Distribution ofAntibiotics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kayla E GrootersDepartment of Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, United States.
Sheridan L HayesDivision of Medical Engineering, Department of Surgical Science, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, United States.
David M RichterDepartment of Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, United States.
Jennifer C KuDepartment of Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, United States.
Robert SawyerDivision of Medical Engineering, Department of Surgical Science, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, United States.
Yong LiDivision of Medical Engineering, Department of Surgical Science, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Infections with coagulase negative staphylococcal species (CoNS) are a major cause of mortality and morbidity in joint and heart valve replacement procedures, largely due to biofilm formation. Cells within biofilms have higher rates of antibiotic resistance than their planktonic counterparts; consequently, novel mechanisms are needed to combat these infections. Methods: To enhance antibiotic delivery and penetration, this innovative study involved treating CoNS biofilms with murine blood clots impregnated with antibiotics. We then investigated the impact of this treatment on biofilm density, metabolism, and architecture. Results: Our pilot study demonstrates that this method of antibiotic delivery results in improved biofilm clearance, relative to conventional exposure methods. Discussion: Our results demonstrate that blood clot exposure has an intrinsic impact on biofilm density and potentially reduces colonization, warrenting further investigation into the mechanism.

Indexed as

Anti-Bacterial AgentsBiofilmsStaphylococcal InfectionsStaphylococcusThrombosisAnimalsDisease Models, AnimalMicePilot ProjectsAnti-Bacterial Agentsantibiotic resistancebiofilmbiomaterialsprosthetic joint infectionsstaphylococci

Identifiers

PMID39958937
PMCPMC11827428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.